BactiQuant AS (OCSE:BACTIQ) ROE %: -109.11% (As of Dec. 2025)


OCSE:BACTIQ BactiQuant AS OCSE:BACTIQ
57 GF Score
Price kr2.52
GF Value kr2.37
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is BactiQuant AS ROE %?

BactiQuant AS OCSE:BACTIQ +1.61% 57 ROE % is -109.11% as of Dec. 2025. GuruFocus rates OCSE:BACTIQ with a GF Score™ of 57/100 and a GF Value™ of kr2.37 (Fairly Valued). The stock has 4 warning signs investors should review. Among 3,009 Industrial Products companies, BactiQuant AS ranks worse than 98.8% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. BactiQuant AS's annualized net income for the quarter that ended in Dec. 2025 was kr-13.78 Mil. BactiQuant AS's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was kr12.63 Mil. Therefore, BactiQuant AS's annualized ROE % for the quarter that ended in Dec. 2025 was -109.11%.

The historical rank and industry rank for BactiQuant AS's ROE % or its related term are showing as below:

OCSE:BACTIQ' s ROE % Range Over the Past 10 Years
Min: -181.75   Med: -85.24   Max: -2.39
Current: -159.93

During the past 8 years, BactiQuant AS's highest ROE % was -2.39%. The lowest was -181.75%. And the median was -85.24%.

OCSE:BACTIQ's ROE % is ranked worse than
98.8% of 3009 companies
in the Industrial Products industry
Industry Median: 5.91 vs OCSE:BACTIQ: -159.93

BactiQuant AS  (OCSE:BACTIQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-13.78/12.63
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-13.78 / 8.41)*(8.41 / 23.3915)*(23.3915 / 12.63)
=Net Margin %*Asset Turnover*Equity Multiplier
=-163.85 %*0.3595*1.8521
=ROA %*Equity Multiplier
=-58.9 %*1.8521
=-109.11 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-13.78/12.63
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-13.78 / -13.78) * (-13.78 / -12.212) * (-12.212 / 8.41) * (8.41 / 23.3915) * (23.3915 / 12.63)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 1.1284 * -145.21 % * 0.3595 * 1.8521
=-109.11 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


BactiQuant AS ROE % Related Terms


BactiQuant AS ROE % Historical Data

* Premium members only.

The historical data trend for BactiQuant AS's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BactiQuant AS ROE % Chart

BactiQuant AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial -90.26 -80.21 -91.26 -181.75 -154.13

BactiQuant AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -122.60 -142.80 -326.68 -319.66 -109.11

OCSE:BACTIQ vs VLTO, ZWS, CECO: ROE % Comparison

For the Pollution & Treatment Controls subindustry, BactiQuant AS's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BactiQuant AS ROE % vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, BactiQuant AS's ROE % distribution charts can be found below:

* The bar in red indicates where BactiQuant AS's ROE % falls into.


OCSE:BACTIQ
57GF Score
BactiQuant AS OCSE:BACTIQ
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BactiQuant AS ROE % Calculation

BactiQuant AS's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-13.833/( (0.689+17.261)/ 2 )
=-13.833/8.975
=-154.13 %

BactiQuant AS's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-13.78/( (7.999+17.261)/ 2 )
=-13.78/12.63
=-109.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -109.11% mean?
BactiQuant AS (OCSE:BACTIQ) has a ROE % of -109.11% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BactiQuant AS and its competitors. According to the industry distribution chart, BactiQuant AS ranks #2973 out of 3009 companies in the Industrial Products industry, placing it in the top 98.8%.
Is BactiQuant AS's ROE % too high?
BactiQuant AS's current ROE % is -109.11%. Based on the distribution chart, BactiQuant AS ranks #2973 out of 3009 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, BactiQuant AS has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's ROE % compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #2973 out of 3009 companies for ROE %. This places BactiQuant AS in the lower half of its industry. The industry median ROE % is 5.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 5.91, based on 3,009 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median ROE % is 5.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current ROE % is -109.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.37, compared to a current price of kr2.52 — trading 6.3% above its estimated fair value. The current ROE % is -109.11%. BactiQuant AS's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current ROE % is -109.11% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?

Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued. The current stock price of kr2.52 is trading 6.3% above its estimated GF Value™ of kr2.37. GuruFocus considers BactiQuant AS to be Fairly Valued.

Key valuation signals for OCSE:BACTIQ:

  • ROE %: -109.11%
  • GF Value™: kr2.37 vs. price of kr2.52 (6.3% above fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BactiQuant AS Business Description

Address Blokken 75, Birkeroed, DNK, DK-3460
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
57GF Score

Get the complete analysis for OCSE:BACTIQ

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.52
Price
kr2.37
GF Value